Genetic Therapy Inc. (NASDAQ:GTII) of Gaithersburg, Md., saidit filed with the U.S. Securities and Exchange Commission (SEC)for a public offering of 2 million common shares. Smith Barneyand Montgomery Securities are underwriters for the offering.
Proceeds will be used mainly to fund the company's researchand development activities.
(c) 1997 American Health Consultants. All rights reserved.